Anaptysbio Shares Surge 5.52% Amid Volatility, Outpacing Peers
Anaptysbio shares rise 5.52% amid market volatility, showing stronger gains than peers and growing investor confidence in its cancer therapy pipeline.
2 minutes to read
ANAPTYSBIO INC
Anaptysbio Shares Drop 7.7% as Investors Weigh Clinical and Market Risks
Anaptysbio (ANAB) dips 7.7% as investors weigh stalled clinical milestones, fierce competition, and cash‑burn risks – a cautionary look at its volatile biotech stock.
4 minutes to read